Envisioning 2.0

The New York Times reports today that senators Michael B. Enzi and Edward M. Kennedy of Massachusetts are developing legislation that would impact how drug companies report clinical trial data and monitor drug safety.  The senators are being very coy about the details of the new legislation, which may be presented to Congress after the election season.  Click here to read more (registration required).

This entry was posted on June 22, 2006 at 11:02 am and is filed under FDA and the Pharmaceutical Industry, The Pharmaceutical Industry. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.